-
LONDON: UK’s India Gate To Commemorate Role Of Indian Soldiers From World Wars - 14 hours ago
-
HARARE: Shri Bramha Kumar appointed as the next Ambassador of India to the Republic of Zimbabwe - 24 hours ago
-
LONDON: Indian-Origin Principal Wins UK Legal Challenge Over School Prayer Ban - 1 day ago
-
TORONTO: Indian-Origin Doctor Needs ₹ 2 Crore For Legal Fees. Elon Musk Responds - April 22, 2024
-
KINSHASA: India-Democratic Republic of Congo Foreign Office Consultations - April 21, 2024
-
LONDON: UK Court Allows Sale Of Nirav Modi’s Luxury London Apartment - April 21, 2024
-
TEHRAN: Travel advisory for Iran and Israel - April 20, 2024
-
LUXEMBOURG: Shri Saurabh Kumar concurrently accredited as the next Ambassador of India to the Grand Duchy of Luxembourg - April 20, 2024
-
WASHINGTON: Meet Jigar Shah, Indian-American Named In TIME Most Influential List - April 20, 2024
-
LONDON: What Impact Will New UK Family Visa Rule Have On Indians - April 20, 2024
LUSAKA : India offers support for Africa to fight the Omicron variant
LUSAKA : We have noted the emergence of a new variant of Covid-19, Omicron. We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant.
The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines. Supplies can be undertaken through COVAX or bilaterally.
In this regard, the Government has cleared all orders placed so far by COVAX for supplies of COVISHIELD vaccines including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. We have also cleared supplies of COVAXIN to Botswana.
Any new requirement projected either bilaterally or through COVAX will be considered expeditiously. India also stands ready to supply essential life-saving drugs, test kits, gloves, PPE kits and medical equipment such as ventilators, as may be required.
Indian institutions would favourably consider cooperation in genomic surveillance and virus characterization related research work with their African counterparts. India has, so far, supplied more than 25 million doses of Made-in-India vaccines to 41 countries in Africa, including nearly 1 million doses as grant to 16 countries and more than 16 million doses under the COVAX facility to 33 countries.]